Pooja Toshniwal Paharia

A post-hoc analysis of two phase 2 trials links retatrutide to shifts in fatty acid oxidation, insulin-resistance biomarkers, and lipid metabolism, offering

Ascites in ovarian cancer may do far more than signal advanced disease. Researchers found the fluid actively rewires tumor metabolism to protect

A new generation of synthetic antibiotics wiped out dormant MRSA cells, suppressed bacterial virulence, and avoided detectable resistance in lab studies, offering a promising new weapon against hard-to-treat superbug infections.

Introduction Why Emerging Contaminants Are Difficult to Detect Analytical Technologies Used in 2026 The Rise of Non-Targeted and AI-Assisted Analysis

By connecting personal health data with climate forecasts and food logistics, AI could reshape how food is grown, delivered, and recommended, but

Scientists discovered that horseshoe bats don't just hear better in cluttered forests; they actively reshape the acoustic landscape around them, creating quiet frequency zones that make fluttering prey easier to detect.

A new physics-informed AI framework turns MRI tracer data into detailed maps of brain fluid movement, revealing how slow diffusion and faster directed flow may shape the brain's waste-clearing system.

New Alzheimer's drugs are raising hopes, but modest benefits, ARIA safety risks, high costs, and regulatory disagreements show how uncertain the path to meaningful treatment remains.

From medical nutrition therapy and chronic disease management to wellness coaching and preventive nutrition, understanding the differences between RDNs and nutritionists can help patients choose the right nutrition professional for their health needs.

Researchers developed Passive Heart-Rate Monitoring, a deep-learning smartphone system that estimates heart rate and daily resting heart rate from eight-second facial videos captured during normal phone use. Validated on more than 160,000 videos, the system met accuracy targets across skin-tone groups, although usable measurement rates were lower in the darkest skin-tone group and clinical use still requires further testing.